Solve My Problem: Using a laser to return stability to failing implants

Publication
Article
Dental Products ReportDental Products Report November 2019
Volume 53
Issue 11

The Problem

Dental implants can be an ideal treatment, but peri-implantitis can put implant stability and treatment success at risk

Peri-implantitis is an inflammation in the gingiva around the site of a dental implant, and when untreated it can lead to bone loss around the implant, eventually jeopardizing implant stability.

The Solution

PerioLase® MVP-7™ and the LAPIP Protocol

  • The LAPIP protocol is a tissue-sparing, regenerative approach to treating peri-implant mucositis and peri-implantitis using the PerioLase MVP-7

  • The LAPIP protocol targets diseased tissue leaving native tissues intact and removes metal corrosion contaminants in soft tissue walls

  • Creates a clean, sealed, closed environment for wound healing and True Bone Regeneration

  • Immediate treatment to resolve the infection with less pain, less bleeding and less swelling

  • Probe depth reductions via regeneration, not resection

  • Maintain crestal tissue height and increase crestal bone mass around implant

  • No foreign biologics, no exogenous growth factors, no bone grafts, no artificial membranes, no sutures and no scaffolding

For more information contact Millennium Dental Technologies at 888-638-5262 or lanap.com

Related article: Using a laser for simplified gum disease treatment

Recent Videos
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
Greater New York Dental Meeting 2023 – Interview with Len Tau, DMD
Greater New York Dental Meeting 2023 – Interview with Hope Slowik
Greater New York Dental Meeting 2023 – Interview with Branden Neish, MBA
Greater New York Dental Meeting 2023 — Interview with Shannon Carroll, RDH
Greater New York Dental Meeting 2023 – Interview with Edward Goldin, DDS
© 2024 MJH Life Sciences

All rights reserved.